Evidence map›Paper›PMID 30837688›Full record

ArticleMolecular psychiatry2020

Hippocampal mossy cell involvement in behavioral and neurogenic responses to chronic antidepressant treatment.

Seo-Jin Oh, Jia Cheng, Jin-Hyeok Jang, Jeffrey Arace, Minseok Jeong, Chang-Hoon Shin, Jeongrak Park, Junghee Jin, Paul Greengard, Yong-Seok Oh

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Anxiety and hippocampal neuronal activity: Relationship and potential mechanisms.Cognitive, affective & behavioral neuroscience · 2022
    Review
  18. Adaptive Mossy Cell Circuit Plasticity after Status Epilepticus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Seo-Jin Oh *Department of Brain-Cognitive Science, Daegu-Gyeongbuk Institute of Science and Technology (DGIST), Hyenpung-myeon, Dalseong-gun, Daegu, Republic of Korea.
Jia Cheng *Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, 10065, USA.
Jin-Hyeok JangDepartment of Brain-Cognitive Science, Daegu-Gyeongbuk Institute of Science and Technology (DGIST), Hyenpung-myeon, Dalseong-gun, Daegu, Republic of Korea.
Jeffrey AraceLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, 10065, USA.
Minseok JeongDepartment of Brain-Cognitive Science, Daegu-Gyeongbuk Institute of Science and Technology (DGIST), Hyenpung-myeon, Dalseong-gun, Daegu, Republic of Korea.
Chang-Hoon ShinDepartment of Brain-Cognitive Science, Daegu-Gyeongbuk Institute of Science and Technology (DGIST), Hyenpung-myeon, Dalseong-gun, Daegu, Republic of Korea.
Jeongrak ParkDepartment of Brain-Cognitive Science, Daegu-Gyeongbuk Institute of Science and Technology (DGIST), Hyenpung-myeon, Dalseong-gun, Daegu, Republic of Korea.
Junghee JinLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, 10065, USA.
Paul GreengardLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, 10065, USA.
Yong-Seok OhDepartment of Brain-Cognitive Science, Daegu-Gyeongbuk Institute of Science and Technology (DGIST), Hyenpung-myeon, Dalseong-gun, Daegu, Republic of Korea. ysoh2040@dgist.ac.kr.ORCID http://orcid.org/0000-0002-9039-2014
Daegu Gyeongbuk Institute of Science and Technology · KRRockefeller University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most antidepressants, including selective serotonin reuptake inhibitors (SSRIs), initiate their drug actions by rapid elevation of serotonin, but they take several weeks to achieve therapeutic onset. This therapeutic delay suggests slow adaptive changes in multiple neuronal subtypes and their neural circuits over prolonged periods of drug treatment. Mossy cells are excitatory neurons in the dentate hilus that regulate dentate gyrus activity and function. Here we show that neuronal activity of hippocampal mossy cells is enhanced by chronic, but not acute, SSRI administration. Behavioral and neurogenic effects of chronic treatment with the SSRI, fluoxetine, are abolished by mossy cell-specific knockout of p11 or Smarca3 or by an inhibition of the p11/AnxA2/SMARCA3 heterohexamer, an SSRI-inducible protein complex. Furthermore, simple chemogenetic activation of mossy cells using Gq-DREADD is sufficient to elevate the proliferation and survival of the neural stem cells. Conversely, acute chemogenetic inhibition of mossy cells using Gi-DREADD impairs behavioral and neurogenic responses to chronic administration of SSRI. The present data establish that mossy cells play a crucial role in mediating the effects of chronic antidepressant medication. Our results indicate that compounds that target mossy cell activity would be attractive candidates for the development of new antidepressant medications.

Indexed as

AnimalsAntidepressive AgentsCell LineDepressionFluoxetineMiceMossy Fibers, HippocampalNeurogenesisSelective Serotonin Reuptake InhibitorsAntidepressive AgentsFluoxetineSelective Serotonin Reuptake Inhibitors

Identifiers

PMID30837688
OpenAlexW2919782792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.